Clinical or Case Report

Journal of implantology and applied sciences. 30 June 2025. 115-122
https://doi.org/10.32542/implantology.2025012

ABSTRACT


MAIN

  • Ⅰ. Introduction

  • Ⅱ. Case Report

  •   1. Case 1

  •   2. Case 2

  • Ⅲ. Discussion

  • Ⅳ. Conclusion

Ⅰ. Introduction

Inadequate alveolar ridge volume often leads to improper three-dimensional implant positioning, adversely affecting long-term stability and esthetic outcomes.1,2Therefore, horizontal ridge augmentation (HRA) is often essential prior to or in conjunction with implant placement in anatomically unfavorable ridges.

Although guided bone regeneration (GBR) and block bone grafting are commonly used techniques in the posterior mandible, the unfavorable residual ridge morphology in this region can limit the effectiveness of conventional GBR.3,4Furthermore, autogenous block bone grafts are associated with disadvantages such as donor site morbidity, challenges in soft tissue management, and the requirement for graft fixation.5,6

Recombinant human bone morphogenetic protein-2 (rhBMP-2) is a potent osteoinductive factor that promotes osteoblast proliferation, osteogenic differentiation, and mesenchymal cell recruitment.7,8 Owing to its low molecular weight and high solubility, rhBMP-2 readily diffuses into body fluids; therefore, employing a suitable carrier matrix is imperative.9,10

Acellular dermal matrix (ADM), originally developed as a dermal substitute for skin grafting, has been adapted for dental applications as a substitute for autogenous connective tissue grafts and as a barrier membrane in periodontal regenerative procedures. ADM offers several advantages including high tensile strength, excellent clinical workability, resistance to infection, and the promotion of neovascularization owing to its high collagen content.11 These properties suggest that ADM may be a promising carrier for rhBMP-2 in bone regeneration.

This report presents two clinical cases in which rhBMP-2-loaded ADM was applied to patients with flat and steep buccal alveolar slopes in the posterior mandible, with the primary aim of achieving horizontal bone augmentation. Clinical and radiographic outcomes, as well as subsequent functional loading of the implants were evaluated.

Ⅱ. Case Report

1. Case 1

A 63-year-old female with no significant systemic medical history visited our clinic for implant placement at the mandibular left first premolar, which had been extracted 4 months earlier due to dental caries. Preoperative clinical and radiographic examination revealed a flat residual ridge with a steep buccal slope. Ideal prosthetically driven implant placement resulted in buccal thread exposure, necessitating simultaneous HRA (Fig. 1).

https://cdn.apub.kr/journalsite/sites/kaomi/2025-029-02/N0880290206/images/kaomi_29_02_06_F1.jpg
Fig. 1

(A) Panoramic radiograph taken immediately before implant placement. (B) Intraoral clinical view showing the steep and narrow alveolar ridge.

To compensate for the anticipated horizontal deficiency of approximately 1.5 mm, bone grafting was planned using a combination of dehydrated ADM (MegaDerm® thickness: 0.3–0.6 mm; L & C Bio, Seoul, Korea) loaded with rhBMP-2 (Novosis®; CGbio, Seoul, Korea).

Under local anesthesia with 2% lidocaine, a crestal incision was made and a full-thickness mucoperiosteal flap was elevated. A 3.5 mm diameter implant was placed according to prosthetic considerations, followed by cover screw installation. As expected, the buccal threads were exposed immediately after placement. The ADM was trimmed to fully cover all areas where buccal bone thickness was clinically less than 1.5 mm, and then immersed in 0.25 mg rhBMP-2 dissolved in 0.5 mL of normal saline for 1 min. The soaked ADM was folded once, directly applied to the defect site, and secured with simple interrupted sutures (Fig. 2).

https://cdn.apub.kr/journalsite/sites/kaomi/2025-029-02/N0880290206/images/kaomi_29_02_06_F2.jpg
Fig. 2

(A) Buccal implant thread exposure observed immediately after implant placement. (B) Application of acellular dermal matrix (ADM) loaded with recombinant human bone morphogenetic protein-2 (rhBMP-2) over the defect site.

At the 6-month follow-up, the patient returned for second-stage surgery. Flap reflection revealed that the area previously covered by the ADM had been replaced with newly formed bone. Approximately 1.5 mm of horizontal bone gain was observed, and the previously exposed buccal implant threads were now completely covered by new bone (Fig. 3).

https://cdn.apub.kr/journalsite/sites/kaomi/2025-029-02/N0880290206/images/kaomi_29_02_06_F3.jpg
Fig. 3

(A) Clinical photograph showing horizontally augmented alveolar ridge six months after implant placement. (B) Clinical photograph after removal of the cover screw. (C) Six-month postoperative panoramic radiograph. Showing the newly formed bone (white arrow), measuring approximately 1.5 mm in width.

No signs of peri-implantitis or soft tissue inflammation were observed during the 13-month follow-up period after prosthetic loading.

2. Case 2

A 57-year-old female undergoing continuous ambulatory peritoneal dialysis at our hospital for end-stage renal disease visited our clinic for implant placement at the mandibular left first molar site, which had been lost due to chronic periodontitis. As alveolar bone loss progressed, the left mandibular second molar was considered non-restorable. As a result, the second molar was scheduled for extraction, and an implant was planned for the first molar site (Fig. 4).

https://cdn.apub.kr/journalsite/sites/kaomi/2025-029-02/N0880290206/images/kaomi_29_02_06_F4.jpg
Fig. 4

(A) Panoramic radiograph taken before implant placement. (B) Clinical photograph showing a narrow and straight alveolar ridge in the posterior mandible.

Preoperative cone-beam computed tomography (CBCT) revealed horizontal alveolar bone deficiency due to long-term edentulism. To ensure long-term implant success, approximately 1–2 mm of HRA was considered necessary. Accordingly, simultaneous placement of a 4 mm diameter implant was planned, along with HRA using ADM loaded with rhBMP-2.

During surgery, the dehydrated ADM was carefully cut and folded to achieve a total thickness of approximately 0.6–1.2 mm. It was then immersed in 0.25 mg of rhBMP-2 dissolved in 0.5 mL of normal saline for 1 min. The prepared ADM was applied to the buccal bone defect and a titanium fixation screw was used to stabilize the graft material in position (Fig. 5). The surgical site was then carefully closed using simple interrupted sutures.

https://cdn.apub.kr/journalsite/sites/kaomi/2025-029-02/N0880290206/images/kaomi_29_02_06_F5.jpg
Fig. 5

Stabilization of the acellular dermal matrix using a fixation screw.

CBCT analysis performed 5 months postoperatively confirmed a horizontal bone gain of approximately 1.7 mm. Newly formed bone with homogeneous density and continuity was observed around the implant (Fig. 6). Throughout the 10-month functional loading period, no signs of inflammation, bone resorption, or other complications were observed in the surrounding hard or soft tissues. The implant remained functionally stable.

https://cdn.apub.kr/journalsite/sites/kaomi/2025-029-02/N0880290206/images/kaomi_29_02_06_F6.jpg
Fig. 6

(A) Preoperative cone-beam computed tomography (CBCT) scan showing the alveolar bone width at the level corresponding to the fixation screw position in the postoperative scan. (B) CBCT scan 5 months postoperatively showing a horizontal bone gain of 1.7 mm. (C) Sagittal CBCT view showing buccal cortical bone thickness at the level of the bone crest and 2 mm below the crest after surgery. (D) Panoramic radiograph after functional loading.

Ⅲ. Discussion

ADM has been widely utilized as a scaffold material in various reconstructive procedures because of its high collagen content and mechanical stability.12,13 More recently, its applications have expanded into the dental field, including periodontal plastic surgery and bone regeneration techniques.14,15 Unlike conventional collagen sponges or synthetic materials such as β-tricalcium phosphate, ADM provides a biologically active matrix that supports cell adhesion, migration, neovascularization, and soft tissue integration.16,17,18

These properties make ADM a promising carrier for rhBMP-2, potentially enhancing bone regeneration. The combination of ADM and rhBMP-2 has demonstrated osteoinductive potential in animal models. Previous animal studies demonstrated partial replacement of ADM by dense collagen bundles and elastic fibers, accompanied by progressive new bone formation.19 However, clinical studies evaluating the use of this combination in humans—particularly under functional loading conditions—remain limited. In the present cases, ADM effectively served as both a delivery system for rhBMP-2 and as a structural scaffold that maintained space at the defect site, thereby facilitating predictable bone regeneration.

A clinically significant consideration is whether the regenerated bone can support long-term functional loading of the implant. In this study, both CBCT and clinical evaluations confirmed that the newly formed bone was continuous with the native alveolar ridge. Furthermore, stable peri-implant conditions were observed without any signs of inflammation or bone loss during follow-up periods of 13 and 10 months, respectively. These findings strongly suggest that ADM-based ridge augmentation may contribute not only to short-term bone formation but also to sustained long-term implant survival and stability.

Nevertheless, a limitation of this study is the absence of histological evaluation, which restricts deeper assessment of the biological characteristics of the regenerated bone. In addition, long-term follow-up periods are necessary to further verify the sustained stability of the augmented sites.

Despite these limitations, this case report demonstrated the clinical feasibility of using rhBMP-2-loaded ADM for horizontal ridge augmentation in humans. This method yielded favorable bone regeneration outcomes and maintained stable implant conditions under short-term functional loading. Further prospective, controlled studies, including histological analyses, are warranted to validate the broader applicability of this approach in implant dentistry.

Ⅳ. Conclusion

This case report demonstrates that ADM loaded with rhBMP-2 can effectively induce predictable horizontal bone augmentation in the posterior mandibular region without the need for additional grafting materials or barrier membranes. The regenerated bone provided stable support for functional implant loading. Owing to its ease of handling and the ability to achieve tension-free primary closure without additional procedures, this technique offers both clinical efficiency and procedural safety in cases requiring limited augmentation. Further prospective studies with long-term follow-up are warranted to further validate and expand the clinical applicability of this approach.

Informed Consent Statement

Informed consent was obtained from the subjects involved in the study.

Conflicts of Interest

The authors declare no conflict of interest.

References

1

Papathanasiou I, Vasilakos G, Baltiras S, Zouloumis L. Ridge splitting technique for horizontal augmentation and immediate implant placement. Balk J Dent Med 2014;18:41-7.

10.1515/bjdm-2015-0007
2

Xu X, Xu P, Liu S, Yang Y, Cheng Y, Zhang W, et al. Clinical study on horizontal bone augmentation using an alveolar mucosa-periosteal bone flap. BMC Oral Health 2025;25:202.

10.1186/s12903-025-05539-939923076PMC11806868
3

Aghaloo TL, Moy PK. Which hard tissue augmentation techniques are the most successful in furnishing bony support for implant placement? Int J Oral Maxillofac Implants 2007;22(Suppl):49-70.

18437791
4

Simion M, Baldoni M, Zaffe D. Jawbone enlargement using immediate implant placement associated with a resorbable membrane and a particulate autogenous bone graft: a case report. Int J Periodontics Restorative Dent 1992;12:462-73.

1298734
5

Nkenke E, Schultze-Mosgau S, Radespiel-Tröger M, Kloss F, Neukam FW. Morbidity of harvesting of bone grafts from the iliac crest for preprosthetic augmentation procedures: a prospective study. Int J Oral Maxillofac Surg 2004;33:157-63.

10.1054/ijom.2003.046515050072
6

SanzSánchez I, OrtizVigón A, Figueiredo R, Molina A, Sanz M, et al. Complications in bonegrafting procedures. Periodontol 2000 2022;90:77-94.

7

Yamaguchi A, Komori T, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins. J Bone Miner Res 2000;15:1-9.

10.1210/edrv.21.4.040310950158
8

Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 1998;346:26-37.

10.1097/00003086-199801000-00006
9

Wozney JM. The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult. Eur J Oral Sci 1998;106(Suppl 1):160-6.

10.1111/j.1600-0722.1998.tb02170.x9541220
10

Seo JI, Lim JH, Jo WM, Lee JK, Song SI. Effects of rhBMP-2 with various carriers on maxillofacial bone regeneration through computed tomography evaluation. Maxillofac Plast Reconstr Surg 2023;45:40.

10.1186/s40902-023-00405-637889372PMC10611676
11

Sanz M, Simion M. Surgical techniques on periodontal plastic surgery and soft tissue regeneration. J Clin Periodontol 2005;32(Suppl 6):121-6.

12

Prantl L, Santosa KB. Acellular dermal matrices: Use in reconstructive and aesthetic breast surgery. Can J Plast Surg. 2012;20:71-6.

10.4172/plastic-surgery.1000739
13

Dilek ÖF, Sevim KZ, Dilek ON. Acellular dermal matrices in reconstructive surgery; history, current implications and future perspectives for surgeons. World J Clin Cases 2024;12:6791-807.

10.12998/wjcc.v12.i35.679139687641PMC11525903
14

Silverstein LH, Callan DP. Acellular dermal matrix: a substitute for palatal donor tissue. J Esthet Restor Dent 2003;15:102-8.

15

Lu W, Qi G, Ding Z, Li X, Qi W, He F. Clinical efficacy of acellular dermal matrix for plastic periodontal and implant surgery: a systematic review. Int J Oral Maxillofac Surg 2020;49:1057-66.

10.1016/j.ijom.2019.12.00531889581
16

Petrie K, Cox CT, Becker BC, MacKay BJ. Clinical applications of acellular dermal matrices: a review. Scars Burn Heal 2022;8:20595131211038313.

10.1177/2059513121103831335083065PMC8785275
17

Eppley BL. Experimental assessment of the revascularization of acellular human dermis for soft tissue augmentation. Plast Reconstr Surg 2001;107:757-62.

10.1097/00006534-200103000-0001611304602
18

Shi Y, Zhang H, Zhang X, Chen Z, Zhao D, Ma J. A comparative study of two porous sponge scaffolds prepared by collagen derived from porcine skin and fish scales as burn wound dressings in a rabbit model. Regen Biomater 2020;7:63-70.

10.1093/rb/rbz03632153992PMC7053267
19

Kim CK, Song DS, Kim TG, Jung UW. Effects of recombinant human bone morphogenetic protein-2 loaded acellular dermal matrix on bon formation in rat calvarial defects. J Korean Acad Periodontol 2007;37:1-10.

10.5051/jkape.2007.37.1.1
페이지 상단으로 이동하기